Literature DB >> 21214383

Effects of 810-nm laser on murine bone-marrow-derived dendritic cells.

Aaron C-H Chen1, Ying-Ying Huang, Sulbha K Sharma, Michael R Hamblin.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the effect of 810-nm low level laser therapy (LLLT) on dendritic cells (DC) in vitro. BACKGROUND DATA: LLLT can enhance wound healing and increase cell proliferation and survival, and is used to treat inflammatory conditions. However there are reports that LLLT can stimulate leukocytes and could therefore be pro-inflammatory. Recently, DC have been found to play an important role in inflammation and immune response.
METHODS: Murine bone-marrow-derived DC were isolated, stimulated with lipopolysaccharide (LPS) or CpG oligodeoxynucleotide and treated with 810-nm laser, using fluences of 0.3, 3, and 30  J/cm(2) delivered at irradiances of 1, 10, and 100  mW/cm(2) respectively. Confocal microscopy, flow cytometry for DC markers, viability using propidium iodide, enzyme-linked immunosorbent assays (ELISA) for secreted interleukin-12 (IL-12), and bioluminescence measurements in cells transduced with a reporter for toll-like receptor (TLR)-9/nuclear factor kappa B (NF-κB) activation, were performed.
RESULTS: LLLT changed the morphology of LPS-stimulated DC, increased their viability, and altered the balance of DC activation markers (major histocompatibility complex [MHC] class 2 up and CD86 down). LLLT reduced IL-12 secretion from DC stimulated by either LPS or CpG. LLLT reduced NF-κB activation in reporter cells stimulated with CpG. There was no obvious light dose response observed.
CONCLUSIONS: Taken together, these data suggest that 810-nm LLLT has an anti-inflammatory effect on activated DC, possibly mediated by cyclic adenosine monophosphate (cAMP) and reduced NF-κB signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21214383      PMCID: PMC3105346          DOI: 10.1089/pho.2010.2837

Source DB:  PubMed          Journal:  Photomed Laser Surg        ISSN: 1549-5418            Impact factor:   2.796


  38 in total

1.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

2.  A randomised, placebo controlled trial of low level laser therapy for activated Achilles tendinitis with microdialysis measurement of peritendinous prostaglandin E2 concentrations.

Authors:  J M Bjordal; R A B Lopes-Martins; V V Iversen
Journal:  Br J Sports Med       Date:  2006-01       Impact factor: 13.800

3.  Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.

Authors:  Doreen Krumbiegel; Fred Zepp; Claudius Ullrich Meyer
Journal:  Hum Immunol       Date:  2007-08-29       Impact factor: 2.850

Review 4.  Orchestration of the immune response by dendritic cells.

Authors:  Matthew R Buckwalter; Matthew L Albert
Journal:  Curr Biol       Date:  2009-05-12       Impact factor: 10.834

5.  Cutaneous immunological activation elicited by a low-fluence pulsed dye laser.

Authors:  T Omi; S Kawana; S Sato; S Takezaki; M Honda; T Igarashi; R W Hankins; P Bjerring; K Thestrup-Pedersen
Journal:  Br J Dermatol       Date:  2005-12       Impact factor: 9.302

6.  In vivo effects of low level laser therapy on inducible nitric oxide synthase.

Authors:  Yumi Moriyama; Jacqueline Nguyen; Margarete Akens; Eduardo H Moriyama; Lothar Lilge
Journal:  Lasers Surg Med       Date:  2009-03       Impact factor: 4.025

7.  Irradiation with 780 nm diode laser attenuates inflammatory cytokines but upregulates nitric oxide in lipopolysaccharide-stimulated macrophages: implications for the prevention of aneurysm progression.

Authors:  Lilach Gavish; Louise S Perez; Petachia Reissman; S David Gertz
Journal:  Lasers Surg Med       Date:  2008-07       Impact factor: 4.025

8.  Low-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time.

Authors:  Ana P Castano; Tianhong Dai; Ilya Yaroslavsky; Richard Cohen; William A Apruzzese; Michael H Smotrich; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2007-07       Impact factor: 4.025

9.  Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

Authors:  T Henkel; T Machleidt; I Alkalay; M Krönke; Y Ben-Neriah; P A Baeuerle
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

10.  cAMP elevators inhibit LPS-induced IL-12 p40 expression by interfering with phosphorylation of p38 MAPK in murine peritoneal macrophages.

Authors:  Wei Guo Feng; Yi Bing Wang; Jin Song Zhang; Xing Yu Wang; Chang Lin Li; Zong Liang Chang
Journal:  Cell Res       Date:  2002-12       Impact factor: 25.617

View more
  15 in total

Review 1.  Role of low-level laser therapy in neurorehabilitation.

Authors:  Javad T Hashmi; Ying-Ying Huang; Bushra Z Osmani; Sulbha K Sharma; Margaret A Naeser; Michael R Hamblin
Journal:  PM R       Date:  2010-12       Impact factor: 2.298

2.  Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports.

Authors:  Margaret A Naeser; Anita Saltmarche; Maxine H Krengel; Michael R Hamblin; Jeffrey A Knight
Journal:  Photomed Laser Surg       Date:  2010-12-23       Impact factor: 2.796

Review 3.  Transcranial low level laser (light) therapy for traumatic brain injury.

Authors:  Ying-Ying Huang; Asheesh Gupta; Daniela Vecchio; Vida J Bil de Arce; Shih-Fong Huang; Weijun Xuan; Michael R Hamblin
Journal:  J Biophotonics       Date:  2012-07-17       Impact factor: 3.207

4.  Photobiomodulation with 660-nm and 780-nm laser on activated J774 macrophage-like cells: Effect on M1 inflammatory markers.

Authors:  Kristianne Porta Santos Fernandes; Nadhia Helena Costa Souza; Raquel Agnelli Mesquita-Ferrari; Daniela de Fatima Teixeira da Silva; Lilia Alves Rocha; Agnelo Neves Alves; Kaline de Brito Sousa; Sandra Kalil Bussadori; Michael R Hamblin; Fábio Daumas Nunes
Journal:  J Photochem Photobiol B       Date:  2015-10-20       Impact factor: 6.252

5.  Transcranial Low-Level Laser (Light) Therapy for Brain Injury.

Authors:  Connor Thunshelle; Michael R Hamblin
Journal:  Photomed Laser Surg       Date:  2016-12       Impact factor: 2.796

Review 6.  Photobiomodulation for traumatic brain injury and stroke.

Authors:  Michael R Hamblin
Journal:  J Neurosci Res       Date:  2017-11-13       Impact factor: 4.164

Review 7.  Brain Photobiomodulation Therapy: a Narrative Review.

Authors:  Farzad Salehpour; Javad Mahmoudi; Farzin Kamari; Saeed Sadigh-Eteghad; Seyed Hossein Rasta; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

Review 8.  Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70.

Authors:  Lydia C Kitchen; Marvin Berman; James Halper; Paul Chazot
Journal:  Int J Mol Sci       Date:  2022-05-07       Impact factor: 6.208

9.  Photobiomodulation and Antiviral Photodynamic Therapy in COVID-19 Management.

Authors:  Reza Fekrazad; Sohrab Asefi; Maryam Pourhajibagher; Farshid Vahdatinia; Sepehr Fekrazad; Abbas Bahador; Heidi Abrahamse; Michael R Hamblin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Low-level laser therapy regulates microglial function through Src-mediated signaling pathways: implications for neurodegenerative diseases.

Authors:  Sheng Song; Feifan Zhou; Wei R Chen
Journal:  J Neuroinflammation       Date:  2012-09-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.